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Abstract
            Myopotential oversensing in implantable defibrillators causing inhibition of pacing and 
inappropriate   therapies   is   well   described.   Current   literature   is   dominated   by   reports   of 
diaphragmatic muscle as the source of such far-field oversensing. Those reporting pectoral 
muscle sources were invariably due to unipolar sensing circuits, incorrect DF-1 connections or 
inappropriate programming. We report an interesting case of pectoral muscle myopotential 
oversensing causing inhibition of bradycardia pacing leading to presyncope and syncope.
Key Words: Myopotential oversensing; implantable defibrillators; inhibition of pacing; 
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Introduction
            Oversensing of skeletal muscle myopotentials is well described1-3 and is common in 
unipolar sensing circuits where a wide sensing field is caused by distance between electrodes 
(the ventricular lead tip and the generator casing [~ 100 - 150 mm]). Dedicated bipolar 
defibrillator   leads   (quadripolar   leads)   can   overcome   this   problem   by   approximating   the 
electrodes (up to ~ 8 mm) within the lead tip, but such constructions complicate lead design and 
may compromise durability4. Integrated bipolar leads simplify lead construction by using a 
portion of the distal defibrillator coil and the lead tip as pace/sense electrodes (total inter-
electrode distance up to ~ 60 mm). Even this degree of electrode spacing renders integrated leads 
susceptible to T wave, P wave and diaphragmatic myopotential oversensing5. We present a case 
highlighting the pitfalls in integrated leads in which there was no T wave, P wave or 
diaphragmatic   oversensing.                                                                    
Case   report                                                                              
            A 60 year old female with hypertrophic cardiomyopathy had originally presented with 
syncope and documented ventricular tachycardia. A dual chamber cardioverter-defibrillator 
(Guidant VENTAK 1861) was implanted in June 2003 and an integrated bipolar right ventricular 
defibrillator lead was used (Guidant SN 0158). Electrogram amplitudes, pacing and defibrillation 
thresholds at the time of implantation were normal.                                                   
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               After the procedure, the patient was without symptoms  for two years. Device 
interrogation   during   routine   follow-up   demonstrated   low   levels   of   noise   on   ventricular 
electrograms. There were no appropriate or inappropriate therapies although three therapies were 
diverted.  
            In Feb 2006 the patient developed persistent atrial fibrillation. Pharmacological attempts 
to maintain sinus rhythm were unsuccessful, she declined a left atrial ablation procedure and in 
May 2007 the patient underwent atrio-ventricular (AV) node ablation for ventricular rate control 
and was rendered pacemaker dependant. One month after AV node ablation the patient attended 
the cardiac device clinic complaining of recurrent episodes of dizziness and syncope during 
certain physical activities such as showering or washing dishes. At this time pacing thresholds, 
electrogram amplitudes and impedances were normal. A chest X-ray showed no radiographic 
evidence of loss of lead integrity.                                                                                   
            Device interrogation revealed 16 diverted therapies in the VF zone. One such episode is 
shown   in  Figure   1.   The   atrial   electrogram   confirms   atrial   fibrillation.   The   ventricular 
electrogram   demonstrates   a   paced   beat   followed   by   potentials   which   are   clearly   not 
physiological.   These   high   frequency   potentials,   detected   within   the   VF   zone   had   two 
consequences - inhibition of ventricular pacing and device capacitor charging. The prolonged 
asystole in this pacing-dependant patient eventually, and rather fortuitously, results in syncope 
which coincides with the disappearance of the non-physiological potentials. As a result, 
ventricular pacing resumes and defibrillation is diverted.
Figure 1. Recorded episode of diverted therapy. Atrial electrogram (top) ventricular electrogram (middle) and 
paced electrogram (bottom). Black arrows indicate non-physiological potentials. 
               At interrogation, these potentials were not reproducible with the usual provocative 
manoeuvres such as rapid, deep respiration and generator agitation, but were reproducible with 
isometric upper limb exercise (palm apposition) and resulted in pacing inhibition and dizziness. 
            Our immediate management was to reduce the sensitivity to the minimum programmable 
setting. This was deemed safe as a short term measure as VF detection at minimal sensitivity was 
confirmed at defibrillation threshold testing at implantation. We advised the patient to avoid 
driving and provocative manoeuvres. The patient was admitted electively for re-operation. At 
procedure the existing lead connections to the generator were found to be secure and appropriate. 
Invasive lead tests were satisfactory. We elected to leave the integrated lead in situ and implant a 
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new dedicated bipolar pacing lead (Medtronic 5076) for ventricular sensing and pacing. The new 
pace/sense lead was connected to the ventricular IS-1 socket on the existing device and the old 
integrated defibrillator lead remained connected via the DF-1 sockets. The defibrillator lead IS-1 
terminal was capped and secured within the prepectoral pocket.   Subsequently, the patient's 
symptoms resolved and no further myopotentials were recordable.                              
Discussion
            The case highlights a problem specific to integrated bipolar lead technology, that is, far-
field myopotential oversensing due to distance between the lead tip and distal defibrillator coil.
            This patient only became symptomatic when rendered pacing dependant after AV node 
ablation when upper body muscular movement caused pacing inhibition through myopotential 
oversensing. Fortunately, this consistently caused dizziness or syncope which stopped physical 
activity thus terminating myopotential oversensing. As a result, therapies were always diverted 
and pacing resumed. It is therefore curious that no inappropriate therapies were delivered prior to 
AV node ablation. This may simply be explained by a dynamic ventricular sensing threshold 
facility available in most defibrillators, in this case, automatic gain control (see  Figure 2). 
Following a sensed ventricular event, there is a blanking period before the initial sensitivity is set 
to 75% of the sensed R wave amplitude. Thereafter, the sensitivity gradually increases to a set 
maximum (typically ~ 0.18 mV). After a paced ventricular event, the initial sensitivity is set 
higher (nominally ~ 3.5 mV). The subsequent rate of sensitivity increase is faster and reaches a 
maximum earlier. Thus, the mechanism of more frequent myopotential oversensing after 
becoming pacing dependant becomes clear. This phenomenon is more easily appreciated in a 
different patient with an implanted defibrillator in Figure 3.
Figure 2. Automatic gain control (red line). See text for explanation. Blanking period (BP), ventricular sensed event 
(VS), ventricular paced event (VP), ventricular fibrillation detection (VF).
            Atrial and T-wave oversensing, which have also been reported with integrated bipolar 
leads   are   usually   easily   overcome   with   re-programming.   True   myopotential   oversensing 
however, invariably requires re-operation. Our solution in this case was to introduce a separate 
dedicated bipolar pace/sense lead and retain the integrated lead for defibrillation. An alternative 
solution would have been to replace the lead with a dedicated bipolar defibrillator lead and either 
extract the integrated lead or leave it redundant6 
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Figure 3.  Ventricular electrograms from an implanted defibrillator interrogation. Noise (black arrows) is only 
detected after paced events (open arrows) resulting in events detected in the VF zone (circled, upper trace). Once 
base rate pacing is reduced, (lower trace), there are no paced events and as a result noise is not detected.
.  
               The alternative to re-operation is to reduce ventricular lead sensitivity to exclude 
unwanted potentials. This particular device had three sensitivity settings - "nominal", "less" and 
"least". Although implant testing is done at "least" sensitivity, VF re-induction at "least" 
sensitivity to confirm VF sensing would have been a reasonable approach (though not without 
risk) as changes in sensing may have occurred with lead maturation. In this case, we employed 
this strategy only as an interim, particularly as "least" sensitivity would not have guaranteed a 
resolution to myopotential oversensing, because it could not be confidently reproduced in the 
setting of the device clinic as myopotential interference may change with patient position and 
activity.  
            With dedicated bipolar (quadripolar) defibrillator leads available, the use of integrated 
leads may be questioned. Quadripolar leads are, however, not without problems. Increased 
pacing  thresholds  and  sensing  latency  causing  ventricular  pseudofusion  and unnecessary 
ventricular pacing are not uncommon7. More problematic is insulation failure resulting in 
inappropriate   therapies4.                                                                  
            Progress in lead technology has not paralleled the rapid advances in generator design and 
technology. Newer quadripolar constructions with active fixation are gaining merit but longevity 
data is still anticipated. Hence, to date lead choice remains at the discretion of the implanter 
rather than guided by evidence.
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